- Dr. Jasjeet Singh Wasir is an eminent Endocrinologist, practicing successfully for more than 20 years.
- He is skilled in Weight Management (Obesity) for Diabetes, Assessment of Heart Attack risk for diabetes patients, Controlling and preventing Heart Attack for diabetes patients.
- He is one of the primary faculty members of Centre for Advanced Diabetes Therapy and Technology.
- He plays the pivotal role in conducting Weight Management Programme at Medanta under the guidance of Dr. Ambarish Mittal.
- He is a member of Medical Council of India (MCI).
Dr. Jasjeet Singh Wasir
- Endocrinologist
- Associate Director MD, MBBS,20 years of experience
- Medanta - The Medicity Hospital
- Gurgaon
![](https://www.unimediks.com/wp-content/uploads/2022/01/dr._jasjeet_singh_wasir-associate_director_endocrinologist_0-1.jpg)
![](https://www.unimediks.com/wp-content/uploads/2022/01/dr._jasjeet_singh_wasir-associate_director_endocrinologist_0-1.jpg)
Dr. Jasjeet Singh Wasir
- Endocrinologist
- Associate Director MD, MBBS,20 years of experience
- Medanta - The Medicity Hospital
- Gurgaon
Profile (Overview)
Specialities
Specialization
- Plantar Fascitis
- Peritoneal Dialysis Lactation Counseling
- Congenital Disorders
- Rheumatic Heart Disease
- Typhoid Fever
- Dengue Fever
- Pituitary Diseases
- Diabetes, Obesity
- Thyroid disorders etc
Work Experience of Dr. Jasjeet Singh Wasir
- Consultant, Sadhu Vaswani Mission Medical Centre, New Delhi
Education
- MD, 2001, University College of Medical Sciences, Delhi University
- MBBS, 1997, Maulana Azad Medical College, Delhi University
Awards
Paper Published
- Associated with research and has published several articles in noted national and international journals:
- A Demonstration Project to Evaluate the Effectiveness and Acceptability of the Joint Asia Diabetes Evaluation (JADE) & Diabetes Monitoring Database (DIAMOND) Programs in Type 2 Diabetic Patients in India.
- ASURF (Asian Study for Evaluation of Cardiovascular Risk Factors). 2013.
- Phenotypic and Genetic Correlates of Diabetes (Non-Type 1). in Young Non-obese Asian Indians in North India and a Pilot Case Control Study to Evaluate the Efficacy of Sitagliptin (DPP-4 inhibitor) in a Sub-group of the Study Population.
- A Phase IIb/IIIa randomized, placebo controlled clinical trial to study the safety and efficacy of MK-0364 in overweight and obese patients with Type 2 Diabetes.
- A case control study to evaluate the effects of a multi-nutritional supplement ‘Protinex-Diabetes’ on metabolic and anthropometric parameters in adult subjects with Type 2 Diabetes Mellitus.
Similar Doctors
![doctor_home](https://www.unimediks.com/wp-content/uploads/2021/07/doctor_home.png)
![](https://www.unimediks.com/wp-content/uploads/2022/01/dr._jasjeet_singh_wasir-associate_director_endocrinologist_0-1.jpg)
Dr. Jasjeet Singh Wasir
Endocrinologist
- Associate Director MD, MBBS,20 years of experience
- Gurgaon
About Doctor
Hospital
Specialization
Treatments
List of Treatments
- Thyroidectomy
- Diabetes Stem Cell Treatment
- Endocrine Stem Cell Therapy
Work Experience of Dr. Jasjeet Singh Wasir
Education
Awards
Paper Published
Doctors Similar To Dr. Jasjeet Singh Wasir
Frequently Asked Questions About Dr. Jasjeet Singh Wasir
Need Help For Treatment?
We help you in selecting best Hospital at best package cost.
Get Help
Get Help